Comerica Bank’s Dyne Therapeutics DYN Stock Holding History

Comerica Bank’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.67M	Sell	85,339 -1,157	-1%	-$21.9K	0.01%	1206
2025 Q3	$1.09M	Buy	86,496 +11,158	+15%	+$127K	﹤0.01%	1494
2025 Q2	$717K	Buy	75,338 +34,162	+83%	+$376K	﹤0.01%	1698
2025 Q1	$431K	Buy	41,176 +5,767	+16%	+$82.5K	﹤0.01%	1923
2024 Q4	$834K	Buy	35,409 +35,234	+20,134%	+$1.04M	﹤0.01%	1651
2024 Q3	$6.29K	Hold	175	–	–	﹤0.01%	3270
2024 Q2	$6.18K	Hold	175	–	–	﹤0.01%	3261
2024 Q1	$4.97K	Hold	175	–	–	﹤0.01%	3342
2023 Q4	$2.33K	Hold	175	–	–	﹤0.01%	3490
2023 Q3	$1.57K	Buy	+175	New	+$1.89K	﹤0.01%	3611

Other funds holding DYN

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Comerica Bank's DYN Position: Q4 2025 in Review

Comerica Bank reduced its Dyne Therapeutics (DYN) stake by 1.3% in Q4 2025, selling an estimated $21.9K and leaving 85,339 shares worth $1.67M. The position accounts for 0.01% of the portfolio, ranked #1206.

Comerica Bank first reported a position in DYN in Q3 2023 and has held it in 10 quarters since. 232 funds tracked by Wall St. Rank hold DYN as of Q4 2025.

Comerica Bank held 85,339 shares of Dyne Therapeutics worth $1.67M as of Q4 2025.
Comerica Bank sold 1,157 Dyne Therapeutics shares in Q4 2025, an estimated $21.9K.
Dyne Therapeutics made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #1206 holding.
Comerica Bank first reported a position in Dyne Therapeutics in Q3 2023 and has held it in 10 quarters since.
232 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.